Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen

Gene Therapy volume 6, pages 629–636 (1999)Cite this article

Abstract

DNA-based immunization is currently being investigated as a new method for the induction of cellular and humoral immunity directed against viral disease and cancer. In the present study we characterized and compared the immune responses induced in mice following particle-bombardment of the skin (‘gene gun’ immunization) with those elicited by intracutaneous injection of a recombinant adenoviral vector. Using the well characterized β-galactosidase (βgal) model Ag system we find that both in vivo gene transfer systems elicit potent and long-lasting anti-βgal-specific CD8+ and CD4+ T cell responses. However, gene gun immunization predominantly promotes the production of anti-βgal antibodies of the γ1 isotype, indicative of a Th2-biased immune response, while intradermal injection of recombinant adenovirus primarily leads to the production of anti-βgal γ2aantibodies, indicative of a Th1-biased immune response. Since viral infections are generally associated with the production of large amounts of IFN-α and IL-12, we investigated whether administration of expression plasmids encoding these Th1-associated cytokines along with antigen-encoding cDNA can influence the nature of the immune response resulting from gene gun immunization. We observed that co-delivery of IFN-α or IL-12 resulted in increased production of anti-βgal γ2aantibodies. This suggests a shift towards a Th1 phenotype of the resulting immune response, thus mimicking a viral infection. Importantly, gene gun immunization of mice with a naturally occurring tumor antigen, the tumor-specific p53 mutant antigen expressed by the chemically induced BALB/c Meth A sarcoma, required co-delivery of IL-12 for the induction of effective antitumor immunity. These results have important implications for the design of clinically relevant gene gun immunization strategies for tumor immunotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Spooner RA, Deonarian MP, Epenetos AA . DNA vaccination for cancer treatment Gene Therapy 1995 2: 173–180

    CAS  PubMed  Google Scholar 

  2. Restifo NP . The new vaccines: building viruses that elicit antitumor immunity Curr Opin Immunol 1996 8: 658–663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Conry RM et al. A carcino-embryonic antigen polynucleotide vaccine has in vivo antitumor activity Gene Therapy 1995 2: 59–65

    CAS  PubMed  Google Scholar 

  4. Condon C et al. DNA-based immunization by in vivo transfection of dendritic cells Nature Med 1996 2: 1122–1128

    Article  CAS  PubMed  Google Scholar 

  5. Irvine KR, Rao RB, Rosenberg SA, Restifo NP . Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases J Immunol 1996 156: 238–245

    CAS  PubMed  Google Scholar 

  6. Chen PW et al. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen J Immunol 1996 156: 224–231

    CAS  PubMed  Google Scholar 

  7. Warnier G et al. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A Int J Cancer 1996 67: 303–310

    Article  CAS  PubMed  Google Scholar 

  8. Kumar V, Sercarz E . Genetic vaccination: the advantages of going naked Nature Med 1996 2: 857–859

    Article  CAS  PubMed  Google Scholar 

  9. Pertmer TM, Roberts TR, Haynes JR . Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery J Virol 1996 76: 6119–6125

    Google Scholar 

  10. Feltquate DM, Heaney S, Webster RG, Robinson HL . Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J Immunol 1997 158: 2278–2284

    CAS  PubMed  Google Scholar 

  11. Zitvogel L et al. Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and Th associated cytokines J Exp Med 1996 183: 87–97

    Article  CAS  PubMed  Google Scholar 

  12. Stavnezer J . Immunoglobulin class switching Curr Opin Immunol 1996 8: 199–205

    Article  CAS  PubMed  Google Scholar 

  13. Finkelman FD et al. Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice J Exp Med 1991 174: 1179–1188

    Article  CAS  PubMed  Google Scholar 

  14. Noguchi Y, Richards EC, Chen Y-T, Old LJ . A mouse mutant p53 product recognized by CD4+ and CD8+ T cells Proc Natl Acad Sci USA 1994 91: 3171–3175

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mayordomo JI et al. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines J Exp Med 1996 183: 1357–1365

    Article  CAS  PubMed  Google Scholar 

  16. Raz E et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc Natl Acad Sci USA 1996 91: 9519–9523

    Article  Google Scholar 

  17. Sato Y et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 1996 273: 352–354

    Article  CAS  PubMed  Google Scholar 

  18. Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants Nature Med 1997 3: 849–854

    Article  CAS  PubMed  Google Scholar 

  19. Kim JJ et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen J Immunol 1997 158: 816–826

    CAS  PubMed  Google Scholar 

  20. Geissler M, Gesien A, Tokushige K, Wands JR . Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids J Immunol 1997 158: 1231–1237

    CAS  PubMed  Google Scholar 

  21. Tsuji T et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid espressing IL-12 J Immunol 1997 158: 4008–4013

    CAS  PubMed  Google Scholar 

  22. Noguchi Y, Richards EC, Chen Y-T, Old LJ . Influence of interleukin-12 on p53 peptide vaccination against established Meth A sarcoma Proc Natl Acad Sci USA 1995 92: 2219–2223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ikeda H et al. Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma Proc Natl Acad Sci USA 1997 94: 6375–6379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Brattain MG et al. Establishment of mouse colonic carcinoma cell lines with different metastatic properties Cancer Res 1980 40: 2142–2146

    CAS  PubMed  Google Scholar 

  25. DeLeo AB et al. Cell surface antigens of chemically induced sarcomas of the mouse. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma J Exp Med 1977 146: 720–734

    Article  CAS  PubMed  Google Scholar 

  26. Tüting T et al. Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor Gene Therapy 1997 4: 1053–1060

    Article  PubMed  Google Scholar 

  27. Rakhmilevich AL et al. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors Proc Natl Acad Sci USA 1996 93: 6291–6296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Graham FL, Prevec L . Adenovirus-based expression vectors and recombinant vaccines Biotechnology 1992 20: 363–390

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    T Tüting & A B DeLeo

  2. Department of Dermatology, J-Gutenberg University, Mainz, Germany

    T Tüting

  3. Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    A Gambotto, P D Robbins & W J Storkus

  4. Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    W J Storkus

  5. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    W J Storkus & A B DeLeo

Authors
  1. T Tüting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Gambotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P D Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W J Storkus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A B DeLeo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tüting, T., Gambotto, A., Robbins, P. et al. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen. Gene Ther 6, 629–636 (1999). https://doi.org/10.1038/sj.gt.3300859

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300859

Keywords

This article is cited by

Search

Advanced search

Quick links